A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas.
about
A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A single center phase II study ...... r peripheral T-cell lymphomas.
@en
A single center phase II study ...... r peripheral T-cell lymphomas.
@nl
type
label
A single center phase II study ...... r peripheral T-cell lymphomas.
@en
A single center phase II study ...... r peripheral T-cell lymphomas.
@nl
prefLabel
A single center phase II study ...... r peripheral T-cell lymphomas.
@en
A single center phase II study ...... r peripheral T-cell lymphomas.
@nl
P2093
P2860
P356
P1476
A single center phase II study ...... or peripheral T-cell lymphomas
@en
P2093
Alexandra C Hristov
Avery Polk
Mark S Kaminski
Noah Brown
Philip S Boonstra
Sumana Devata
Tera Mayer
Tycel Phillips
P2860
P304
P356
10.1002/AJH.24895
P577
2017-09-25T00:00:00Z